Prevalence of infection among first accepted tests from female participants (16–24 years) depending on reason for testing
| Portsmouth | ||||||
|---|---|---|---|---|---|---|
| Group 1* | Group 2* | Group 3* | ||||
| Healthcare setting | Number positive (n) | Prevalence (%, 95% CI) | Number positive (n) | Prevalence (%, 95% CI) | Number positive (n) | Prevalence (%, 95% CI) |
| General practice | 47 | 14.6 (11.0 to 19.0) | 209 | 10.0 (8.8 to 11.4) | 310 | 7.9 (7.1 to 8.8) |
| Family planning | 9 | 15.8 (7.5 to 27.9) | 88 | 9.6 (7.8 to 11.7) | 163 | 8.8 (7.6 to 10.2) |
| GUM | 176 | 14.1 (12.2 to 16.2) | 5 | 18.5 (6.3 to 38.1) | 42 | 12.1 (8.9 to 16.1) |
| Youth sexual health clinics | 0 | 0 | 5 | 10.4 (3.5 to 22.7) | 25 | 13.6 (9.0 to 19.4) |
| Wirral | ||||||
|---|---|---|---|---|---|---|
| Group 1* | Group 2* | Group 3* | ||||
| Healthcare setting | Number positive (n) | Prevalence (%, 95% CI) | Number positive (n) | Prevalence (%, 95% CI) | Number positive (n) | Prevalence (%, 95% CI) |
| *Episodes from first accepted tested as categorised as: group 1: Those who either reported symptoms of chlamydial infection and attended for this reason or attended for GUM screening; group 2: Those who attended for another reason but reported symptoms on the form (“opportunistic screening” as would not normally be tested); group 3: Those who were asymptomatic (“opportunistic screening”). All groups are mutually exclusive and episodes where reason for test is unknown have been excluded. | ||||||
| General practice | 24 | 16.8 (11.1 to 23.9) | 37 | 9.0 (6.4 to 12.2) | 56 | 7.7 (5.8 to 9.8) |
| Family planning | 0 | 0 | 29 | 9.8 (6.7 to 13.8) | 63 | 8.8 (6.9 to 11.2) |
| GUM | 90 | 19.4 (15.9 to 23.3) | 88 | 24.9 (20.4 to 29.7) | 23 | 15.9 (10.3 to 22.8) |
| Youth sexual health clinics | 1 | 10.0 (0.3 to 44.5) | 42 | 13.4 (9.8 to 17.7) | 77 | 9.7 (7.7 to 12.0) |